LANCIOTTI, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 15.607
NA - Nord America 4.527
AS - Asia 1.745
SA - Sud America 222
AF - Africa 66
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 22.195
Nazione #
IT - Italia 8.384
PL - Polonia 4.999
US - Stati Uniti d'America 4.457
RU - Federazione Russa 853
SG - Singapore 461
CN - Cina 351
HK - Hong Kong 237
NL - Olanda 230
FR - Francia 219
VN - Vietnam 210
IE - Irlanda 207
SE - Svezia 203
BR - Brasile 174
KR - Corea 114
CH - Svizzera 109
FI - Finlandia 89
DE - Germania 88
GB - Regno Unito 71
IN - India 62
UA - Ucraina 58
JP - Giappone 52
ID - Indonesia 48
CA - Canada 46
BD - Bangladesh 41
TR - Turchia 38
JO - Giordania 27
AU - Australia 26
ES - Italia 26
TH - Thailandia 19
BE - Belgio 18
AR - Argentina 15
CI - Costa d'Avorio 15
NP - Nepal 15
MX - Messico 11
PK - Pakistan 11
RO - Romania 11
IQ - Iraq 10
TN - Tunisia 10
CL - Cile 9
NG - Nigeria 9
IR - Iran 8
MA - Marocco 8
ZA - Sudafrica 8
MY - Malesia 7
PE - Perù 7
EC - Ecuador 6
AT - Austria 5
DK - Danimarca 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
GR - Grecia 4
HR - Croazia 4
IL - Israele 4
KE - Kenya 4
PH - Filippine 4
AM - Armenia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CO - Colombia 3
ET - Etiopia 3
HN - Honduras 3
NO - Norvegia 3
PY - Paraguay 3
BO - Bolivia 2
CR - Costa Rica 2
DM - Dominica 2
EE - Estonia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
PT - Portogallo 2
SM - San Marino 2
SV - El Salvador 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GI - Gibilterra 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 22.191
Città #
Warsaw 4.985
Santa Clara 711
Milan 624
Rome 578
Ashburn 439
Fairfield 347
Singapore 321
Florence 255
Dublin 205
Hong Kong 190
Chandler 185
Naples 181
Woodbridge 162
Turin 161
San Jose 149
Houston 144
Bologna 139
Seattle 132
Cambridge 129
Wilmington 125
Beijing 116
Seoul 113
Council Bluffs 92
Bari 82
Torino 82
Catania 75
Bern 73
Dong Ket 70
Princeton 67
Los Angeles 64
Ann Arbor 62
Buffalo 60
Dallas 60
The Dalles 57
Palermo 56
Tokyo 52
Genoa 51
Boardman 48
Lauterbourg 47
Altamura 43
Ho Chi Minh City 42
Parma 41
Jakarta 40
Lawrence 38
Padova 38
New York 37
Boston 36
Modena 36
Mumbai 36
Medford 34
Helsinki 31
Trieste 31
Bergamo 30
Brescia 30
Hanoi 30
Pisa 29
Moscow 28
Napoli 28
Verona 28
Venice 26
Livorno 24
Melbourne 23
Treviso 23
Hefei 22
Pescara 22
Reggio Emilia 22
Izmir 21
Perugia 21
Phoenix 21
Vicenza 21
Cagliari 20
Toronto 20
Novara 19
Monza 18
Prato 18
Redwood City 18
Clifton 17
Cosenza 17
Falls Church 17
Jacksonville 17
San Diego 17
Frankfurt am Main 16
Imola 16
Salerno 16
Abidjan 15
Caserta 15
Dearborn 15
Orem 15
Genova 14
Paris 14
Taranto 14
Trento 14
Asti 13
Bangkok 13
Lucca 13
Messina 13
Ravenna 13
Rimini 13
Shanghai 13
Bolzano 12
Totale 12.886
Nome #
IL COINVOLGIMENTO NEOPLASTICO DELL' APICE PROSTATICO È UN FATTORE PROGNOSTICO INDIPENDENTE DI PROGRESSIONE DI MALATTIA DOPO PROSTATECTOMIA RADICALE 3.606
IL POSIZIONAMENTO DELLO STENT URETERALE NELLA PIELOPLASTICA LAPAROSCOPICA:TECNICA ANTEROGRADA VS RETROGRADA 2.097
CONFRONTO TRA PROSTATECTOMIA RADICALE NERVE-SPARING BILATERALE EFFETTUATA CON TECNICA ROBOTICA ANTEROGRADA ED OPEN ANTEROGRADA: RISULTATI DI UN SINGOLO CENTRO AD ALTO VOLUME CHIRURGICO 1.173
RISULTATI FUNZIONALI DELLA PROSTATECTOMIA RADICALE ANTEROGRADA PER IL TRATTAMENTO DEL TUMORE PROSTATICO CLINICAMENTE LOCALIZZATO. 1.145
PROSTATECTOMIA RADICALE A CIELO APERTO ANTEROGRADA VS. RETROGRADA PER ETP PROSTATA IN CASI AD ALTO RISCHIO: ANALISI DEI MARGINI CHIRURGICI IN SETTECENTO PAZIENTI TRATTATI IN CENTRI DI RIFERIMENTO TERZIARI 985
RUOLO DELL’INTERAZIONE TRA FIBROBLASTI STROMALI E CELLULE DI CARCINOMA PROSTATICO NELL’ACQUISIZIONE DI UN FENOTIPO METASTATICO. 810
IL VALORE PROGNOSTICO DELLA CROMOGRANINA A (CGA) PREOPERATORIA NEL CARCINOMA PROSTATICO CLINICAMENTE LOCALIZZATO TRATTATO CON PROSTATECTOMIA RADICALE 771
Pieloplastica laparoscopica transperitoneale sec. anderson-hynes: note di tecnica e risultati d120 casi consecutivi 472
CARATTERISTICHE ANATOMO PATOLOGICHE E IMPATTO PROGNOSTICO DELL'INVASIONE DELLA CAPSULA PERITUMORALE IN PAZIENTI CON RCC A CELLULE CHIARE TRATTATI MEDIANTE CHIRURGIA CONSERVATIVA 396
TRATTAMENTO VIDEOLAPAROSCOPICO DI ENDOMETRIOSI VESCICALE TRIGONALE CON COINVOLGIMENTO AB ESTRINSECO DELL’URETERE PELVICO : PRESENTAZIONE DI UN CASO CLINICO 371
Management of sexual dysfunction due to central nervous system disorders: A systematic review 371
Clinical and pathological outcome after radical and nerve sparing anterograde prostatectomy for bioptic Gleason score ≥ 7 and PSA ≥ 10 ng/ml 360
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 360
Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative 352
CURRENT STRATEGIES FOR DIAGNOSIS AND TREATMENT OF BENIGN TUMORS OF SEMINAL VESICLES: A SYSTEMATIC REVIEW OF THE LITERATURE 337
ENUCLEAZIONE TUMORALE VERSUS NEFRECTOMIA RADICALE NELTRATTAMENTO DEL CARCINOMA RENALE INTRACAPSULARE DI DIAMETRO<7 CM 334
HIYSTOPATHOLOGICAL ANALYSIS OF PERITUMORALPSEUDOCAPSULE AND SURGICAL MARGINS STATUS IN RCCAFTER TUMOR ENUCLEATION: PROSPECTIVE SINGLE CENTERSTUDY 330
SIMPLE ENUCLEATION VERSUS RADICAL NEPHRECTOMY IN THE TREATMENT OF pT1a AND pT1b RENAL CELL CARCINOMA 319
ANALYSIS OF THE CLINICAL PARAMETERS COMMONLY USED TO CHOOSE NERVE-SPARING PROSTATECTOMY FOR PATIENTS WITH POSITIVE BIOPSY AT THE TRANSITION ZONE ALONE 318
The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy 311
Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors. 307
RUOLO DEI FATTORI DI RISCHIO METABOLICI NEL RECUPERO FUNZIONALE DOPO PROSTATECTOMIA RADICALE ROBOTICA: DATI PRELIMINARI DI UN SINGOLO CENTRO 307
Simple enucleation versus radical nephrectomy in the treatment of pt1a and pt1b renal cell carcinoma 305
ROLE OF STROMAL FIBROBLASTS INTERACTION WITH PROSTATIC CANCER CELLS IN ACHIEVEMENT OF METASTATIC PHENOTYPE. 303
Role of stromal fibroblasts interaction with prostatic cancer cells in achievement of metastatic phenotype. 290
CONFRONTO DEI RISULTATI ONCOLOGICI E DELLE COMPLICANZE PERIOPERATORIE TRA PROSTATECTOMIA OPEN E ROBOTICA: MATCHED PAIR ANALYSIS SU MILLE PROCEDURE ANTEROGRADE EFFETTUATE IN UN SINGOLO CENTRO AD ALTO VOLUME. 286
CONTROLLO SUTURELESS DELL’EMOSTASI DURANTE NEFRECTOMIA PARZIALE LAPAROSCOPICA PER IL TRATTAMENTO DELLE PICCOLE MASSE RENALI 284
POSSIBLE BIOMARKERS FOR PROSTATE CANCER: DEVELOPMENT AND VALIDATION OF A FULLY AUTOMATED, RAPID, HIGH THROUGH OUT SPME-FAST GC-MS METHOD USING A NEW IONIC LIQUID COLUMN FOR THE DETERMINATION OF SARCOSINE AND N-ETHYLGLYCINE IN URINE AND URINARY SEDIMENTS 273
Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy. 270
THE PROGNOSTIC ROLE OF PREOPERATIVE CHROMOGRANIN A IN CLINICALLY LOCALISED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY 270
URETHRAL PRESERVATION AND ANASTOMOTIC TECHNIQUE DURING OPEN ANTEGRADE RADICAL PROSTATECTOMY: FUNCTIONAL AND ONCOLOGICAL RESULTS 268
CARATTERISTICHE ANATOMOPATOLOGICHE E PROGRESSIONE NEOPLASTICA DOPO PROSTATECTOMIA RADICALE ANTEROGRADA NEI PAZIENTI CON PSA PREOPERATORIO A 20 NG/ML 265
The impact of prior TURP on radical prostatectomy surgical margins: A multicenter analysis and members of the mirror study, LUNA foundation 261
RISULTATI E INDICAZIONI ALLA NSS SUTURELESS VIDEO LAPAROSCOPICA PER IL TRATTAMENTO DELLE PICCOLE MASSE RENALI 256
Proximal hypospadias repair with bladder mucosal graft: Our 10 years experience 254
PATHOLOGICAL OUTCOMES IN PATIENTS CANDIDABLE FOR ACTIVE SURVEILLANCE TREATED WITH RADICAL PROSTATECTOMY. ARE THEY REALLY LOW RISK PATIENTS? 246
MONOLATERAL NERVE-SPARING PROSTATECTOMY: REVIEW OF INDICATIONS, FUNCTIONAL AND ONCOLOGIC OUTCOME 242
A comparison of different oral therapies versus no treatment for erectile dysfunction in 196 radical nerve-sparing radical prostatectomy patients 218
External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection. 202
Fully automated solid-phase microextraction-fast gas chromatography-mass spectrometry method using a new ionic liquid column for high-throughput analysis of sarcosine and N-ethylglycine in human urine and urinary sediments. 196
null 179
ANALYSIS OF THE CLINICAL PARAMETERS COMMONLY USED TO CHOOSE FOR A NERVE-SPARING PROSTATECTOMY IN PATIENTS WITH POSITIVE BIOPSY AT THE TRANSITION ZONE ALONE 176
Current indications and results of orthotopic ileal neobladder for bladder cancer 162
Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study) 156
RECIPROCAL METABOLIC REPROGRAMMING THROUGH LACTATE SHUTTLE COORDINATELY INFLUENCES TUMOR-STROMA INTERPLAY. 155
Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma. 153
Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. 153
Histopathological validation of the Surface-Intermediate-Base (SIB) margin score for standardized reporting of resection techniques during nephron-sparing surgery (NSS) 151
Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer. 145
Prognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer. 145
The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml. 137
The prognostic role of preoperative chromogranin A expression in prostate cancer after radical prostatectomy. 120
Totale 22.353
Categoria #
all - tutte 38.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022865 61 81 94 64 50 38 42 44 52 59 97 183
2022/20232.195 132 161 119 129 197 244 239 236 248 105 180 205
2023/20241.889 131 103 166 163 97 153 166 196 100 183 204 227
2024/20253.842 240 369 338 516 779 377 183 275 308 145 176 136
2025/20263.424 349 404 204 232 316 203 436 185 259 242 196 398
2026/202792 92 0 0 0 0 0 0 0 0 0 0 0
Totale 22.353